Research - Preventive Medicine and Epidemiology Service

The research activity of the Preventive Medicine and Epidemiology Service is carried out by the Research Group on Imported Pathology and Emerging and Reemergent Diseases (GREPIMER) of ISGlobal, accredited as a Group of Excellence by the AGAUR (SGR 2017-2019)

The service's lines of research are as follows:

• Prevention and control of communicable diseases, which include highly communicable diseases.
• Prevention and early detection of breast cancer and colorectal cancer.
• Clinical safety

Participate in vaccines and monoclonal antibodies clinical trials for the prevention of diseases.

The Department of Preventive Medicine and Epidemiology participates in multiple approved clinical trials on vaccines and monoclonal antibodies.

• Vaccines: A vaccine is a product (liquid, aerosol or pill) that is administered to mimic a natural infection with the objective that the body will generate antibodies (defences) against the infection. 

• Monoclonal antibodies: Monoclonal antibodies are molecules produced in the laboratory whose function is to act like human antibodies to prevent and/or fight an infection. 

Vaccines and monoclonal antibodies are used for the prevention of infectious diseases. Prior to its approval and introduction to the market, studies are required to evaluate their safety and efficacy for which volunteers are needed.

What is a Clinical Trial?

More information

If you are interested in participating in these studies, please register here. You will be added to our clinical trial volunteer registry.

If you meet the eligibility criteria for any of our studies, a member of the research team will contact you. 

You may also contact us by telephone at 634 265 812, Monday to Friday from 9:00 to 15:00h OR email at cvac@clinic.cat .